Quality of life measurement in gastroenterology: What is available?

American Journal of Gastroenterology

Volumn 96, Issue 2, 2001, Pages 285-297

  Yacavone, Robert F ^a   Locke III, G Richard ^a   Provenzale, Dawn T ^b   Eisen, Glenn M ^c  

^a MAYO CLINIC   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIGESTIVE SYSTEM CANCER; DYSPEPSIA; ENTERITIS; GASTROENTEROLOGY; GASTROESOPHAGEAL REFLUX; HEALTH STATUS; IRRITABLE COLON; LIVER DISEASE; PATIENT CARE; PRIORITY JOURNAL; QUALITY OF LIFE; RATING SCALE; REVIEW; SCORING SYSTEM; TREATMENT OUTCOME; WELLBEING;

COLONIC DISEASES, FUNCTIONAL; DYSPEPSIA; GASTROINTESTINAL DISEASES; HEALTH STATUS INDICATORS; HUMANS; INFLAMMATORY BOWEL DISEASES; LIVER DISEASES; QUALITY OF LIFE; QUESTIONNAIRES; SICKNESS IMPACT PROFILE;

EID: 0035123685     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(00)02302-9     Document Type: Review

References (76)

1. Assessment of quality-of-life outcomes
2. Health-related quality of life. A primer for gastroenterologists
3. The status of health assessment 1994
4. The sickness impact profile. Development and final revision of a health status measure
5. The Sickness Impact Profile
6. Health status, and health care use in persons with inflammatory bowel disease-A national sample
7. The MOS 36-Item Short-Form Health Survey (SF-36). I. Conceptual framework and item selection
8. The SF-36 Health Survey
9. The MOS Short-Form General Health Survey. Reliability and validity in a patient population
10. Assessing the quality of life of patients with intestinal failure on home parenteral nutrition
11. Impact of irritable bowel syndrome on quality of life
12. Reduction of health-related quality of life in chronic hepatitis C and improvement with interferon therapy
13. Chronic hepatitis C virus infection causes a significant reduction in quality of life in the absence of cirrhosis
14. Symptom differences in moderate to severe IBS patients based on predominant bowel habit
15. Double blind cross-over placebo controlled study of omeprazole in the treatment of patients with reflux symptoms and physiological levels of acid reflux-The "sensitive oesophagus."
16. Nottingham Health Profile
17. Quality of life, major medical complications and hospital service utilization in patients with primary biliary cirrhosis after liver transplantation
18. Relationship of pharmacoeconomics and health-related quality of life
19. Users' guides to the medical literature XII. How to use articles about health-related quality of life
20. The general health policy model: An integrated approach
21. A reader's guide to economic analysis in the GI literature
22. Cost-effectiveness: Definitions and use in the gastroenterology literature
23. Psychological aspects of health-related quality of life measurement. Tests and scales
24. Dimension-specific instruments that may be Used across cultures
25. Quality of life in patients with upper gastrointestinal symptoms. An improved evaluation of treatment regimens?
26. Quality of life during acute, and intermittent treatment of gastro-oesophageal reflux disease with omeprazole compared with ranitidine. Results from a multicentre clinical trial
27. Measuring health-related quality of life
28. Gastrointestinal Quality of Life Index. Development, validation, and application of a new instrument
29. GSRS - A clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease
30. A new measure of health status for clinical trials in inflammatory bowel disease
31. Health-related quality of life in inflammatory bowel disease
32. An index of inflammatory activity in patients with Crohn's disease
33. Correlations between defined sigmoidoscopic appearances and other measures of disease activity in ulcerative colitis
34. Quality of life. A valid and reliable measure of therapeutic efficacy in the treatment of inflammatory bowel disease
35. Oral budesonide for active Crohn's disease
36. Methotrexate for the treatment of Crohn's disease
37. Quality of life in inflammatory bowel disease
38. The Short Inflammatory Bowel Disease Questionnaire: A quality of life instrument for community physicians managing inflammatory bowel disease
39. The SF-36 quality of life measure in inflammatory bowel disease: An evaluation of its reliability and validity
40. Measurement of quality of life of patients with ulcerative colitis undergoing surgery
41. Health-related quality of life in inflammatory bowel disease. Functional status and patient worries and concerns
42. The Rating Form of IBD Patient Concerns. A new measure of health status
43. Ulcerative colitis, and Crohn's disease health status scales for research, and clinical practice
44. Inflammatory bowel disease
45. Quality of life assessment by patients with inflammatory bowel disease
46. Patient-perceived severity of irritable bowel syndrome in relation to symptoms, health resource utilization, and quality of life
47. Evaluation of a new quality of life questionnaire for patients with irritable bowel syndrome
48. Quality of life in persons with irritable bowel syndrome. Development and validation of a new measure
49. Development of a questionnaire to measure quality of life in patients with irritable bowel syndrome
50. Validation of a specific quality of life questionnaire for functional digestive disorders
51. Dyspepsia. How should we measure it?
52. Evaluation of a multidimensional measure of dyspepsia-related health for use in a randomized clinical trial
53. Quality of life in reflux, and dyspepsia patients. Psychometric documentation of a new disease-specific questionnaire (QOLRAD)
54. Development of a digestive health status instrument: Tests of scaling assumptions, structure and reliability in a primary care population
55. Characterization of dyspepsia in a primary care practice
56. Development of a new dyspepsia impact scale: The Nepean Dyspepsia Index (NDI)
57. Validity of a new quality of life scale for functional dyspepsia: A United States multicenter trial of the Nepean Dyspepsia Index
58. Measuring quality of life in dyspeptic patients. Development and validation of a new specific health status questionnaire
59. Quality of life scale for gastroesophageal reflux disease
60. Measuring gastroesophageal reflux disease: Relationship between the health-related quality of life score and physiologic parameters
61. Comparison of generic (SF-36) vs. disease-specific (GERD-HRQL) quality of life scales for gastroesophageal reflux disease
62. Strategies and pitfalls in quality of life research
63. Methods, and outcomes research: Proceedings of workshop sponsored by the AASLD
64. A questionnaire to assess the generic and disease-specific health outcomes of patients with chronic hepatitis C
65. Methods in outcomes research in hepatology. Definitions and domains of quality of life
66. Health-related quality of life in chronic hepatitis C: Impact of disease and treatment response
67. Development of a disease specific questionnaire to measure health related quality of life in patients with chronic liver disease
68. A disease-targeted measure of health-related quality of life (HRQOL) for patients with chronic liver disease. The LDQOL 1.0
69. Development of a disease specific measure for health related quality of life for individuals with chronic pancreatitis
70. Quality-of-life end points in oncology drug trials
71. The construction and testing of the EORTC colorectal cancer-specific quality of life questionnaire module (QLQ-CR38)
72. Reliability and validity of the functional assessment of cancer therapy-colorectal (FACT-C) quality of life instrument
73. A quality-adjusted time without symptoms or toxicity (Q-TWIST) analysis of adjuvant radiation therapy and chemotherapy for resectable rectal cancer
74. Tradeoffs between quality and quantity of life: Development of the QQ Questionnaire for Cancer Patient Attitudes
75. Understanding health care outcomes research
76. Multidisciplinary education is associated with improved outcome in irritable bowel syndrome